Ignite Creation Date:
2024-05-05 @ 12:06 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00249977
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2005-11-02
Brief Title:
Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
Sponsor:
University of New Mexico
Organization:
University of New Mexico
Organization Data
Organization:
University of New Mexico
Class:
OTHER
Study ID:
0103C
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of New Mexico
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Claire Verschraegen MD Principal Investigator
Old Organization:
University of New Mexio - CRTC